PetMeds Faces Internal Audit Investigation After Whistleblower Reports Revenue Recognition Issues - Stock Titan
PetMed Express (NASDAQ: PETS), operating as PetMeds and parent company of PetCareRx, announced it will be unable to file its Form 10-K for FY 2025 within the extension period ending July 1, 2025. T...
Read more